Gene · 1373
Papers2,057
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,057
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integration of 117 machine learning algorithms and single-cell transcriptomics identifies macrophage polarization and ER stress signatures for cancer prognosis and precision therapy. | Discov Oncol | 2026 | 42062606 | PubTator, text mining | PubMed |
| Integrating microbial bioremediation, multi-omics, and emerging technologies for polycyclic aromatic hydrocarbon (PAHs) detoxification. | J Microbiol Methods | 2026 | 42049067 | PubTator, text mining | PubMed |
| KCTD10 as a selective cancer dependency from transcription-replication conflicts (TRCs). | Ageing Cancer Res Treat | 2026 | 42037670 | PubTator, text mining | PubMed |
| Predicting Clinical Outcomes and Immunotherapy Responses in Lung Adenocarcinoma Based on Nicotine Response Characteristics. | Curr Med Chem | 2026 | 41968544 | PubTator, text mining | PubMed |
| Dual roles of MAPK-mediated C/EBPβ phosphorylation in promoting maturation and suppressing EMT during hepatocyte differentiation from hESCs. | Stem Cells | 2026 | 41942108 | PubTator, text mining | PubMed |
| Integrative Analysis of Post-Translational Modifications Identifies a PTM-Enriched Regulatory Core in Human Metabolic Enzymes. | Metabolites | 2026 | 41893314 | PubTator, text mining | PubMed |
| SVNeoPP: A Workflow for Structural-Variant-Derived Neoantigen Prediction and Prioritization Using Multi-Omics Data. | Biology (Basel) | 2026 | 41892252 | PubTator, text mining | PubMed |
| Beta 2 adrenergic receptor agonists as a treatment for metabolic dysfunction-associated steatohepatitis (MASH). | NPJ Metab Health Dis | 2026 | 41882076 | PubTator, text mining | PubMed |
| The oncogenic control of nucleotide synthesis. | Oncogenesis | 2026 | 41881963 | PubTator, text mining | PubMed |
| Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins. | Proc Natl Acad Sci U S A | 2026 | 41875158 | PubTator, text mining | PubMed |
| Genetic Variants Associated with Persistent Pulmonary Hypertension of Newborn: A Systematic Review. | Neonatology | 2026 | 41824641 | PubTator, text mining | PubMed |
| Single Cell Analysis Reveals the Presence of Novel Intermediate Cells in Both Mice and Patients With Severe MASLD. | FASEB J | 2026 | 41811176 | PubTator, text mining | PubMed |
| LncRNAs: key regulators and molecular mechanisms in lung cancer radiosensitivity. | Open Med (Wars) | 2026 | 41798908 | PubTator, text mining | PubMed |
Hyperammonemia-Associated Stroke-Like Episodes and Acute Liver Failure in an 11-Month-Old Infant With Probable Ornithine Transcarbamylase Deficiency: Diagnostic and Therapeutic Challenges in a Resource-Limited Setting. | Cureus | 2026 | 41768218 | PubTator, text mining | PubMed |
| Mechanistic machine learning enables interpretable and generalizable prediction of prime editing outcomes. | bioRxiv | 2026 | 41757025 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway. | Front Oncol | 2026 | 41756322 | PubTator, text mining | PubMed |
| From GWAS Signals to Causal Genes in Chronic Kidney Disease. | Curr Issues Mol Biol | 2026 | 41751412 | PubTator, text mining | PubMed |
| Targeting Fatty Acids in Liver Cancer: Molecular Insights and Drug Approaches. | Biomolecules | 2026 | 41750397 | PubTator, text mining | PubMed |
| Herpes Zoster and Frailty in Older Adults: a Systematic Review. | Can Geriatr J | 2026 | 41743978 | PubTator, text mining | PubMed |
| CA-CAE: A deep learning-based multi-omics model for pan-cancer subtype classification and prognosis prediction. | PLoS Comput Biol | 2026 | 41719374 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1373/papers?page=2